GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLN) » Definitions » Fees and Other Income

Actelion (XSWX:ATLN) Fees and Other Income


View and export this data going back to 2000. Start your Free Trial

What is Actelion Fees and Other Income?

Fees and Other Income only applies to insurance companies.


Actelion (XSWX:ATLN) Business Description

Traded in Other Exchanges
N/A
Address
Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.